Previous 10 | Next 10 |
Gainers: Super Micro Computer SMCI +20%. Charge Enterprises (CRGE) +20%. Cyren CYRN +11%. Enfusion (ENFN) +10%. Zenvia (ZENV) +10%. Losers: Mawson Infrastructure Group MIGI -20%. Arqit Quantum ARQQ -18%. Cerberus Cyber Sentinel (CISO) -13%. Maris-Tech MTEK -...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
The Invesco QQQ ETF has recovered remarkably from its recent bottom. However, we think the NASDAQ would begin consolidating at the current levels for a while. We discuss how investors should think about allocating exposure between predictable growth and speculative growth stocks. ...
We seemed to have emerged from the tech stocks bear market bottom as we moved into Q2'22. We believe the secular themes undergirding tech and growth stocks will continue to play out in Q2. We discuss the key themes that investors should focus on. For further details see: ...
Shares of Enfusion (NYSE: ENFN) , a software-as-a-service company, were falling hard today after the company reported its fourth-quarter results. Enfusion beat Wall Street's consensus estimate for revenue in the quarter but missed analysts' earnings expectations. The tec...
Gainers: Clever Leaves Holdings (CLVR) +33%. NextDecade (NEXT) +23%. Dynagas LNG (DLNG) +23%. Clarus Therapeutics (CRXT) +23%. Amylyx (AMLX) +20%. Hoegh LNG Partners LP (HMLP) +21%. Kidpik (PIK) +19%. Agrify (AGFY) +17%. NexImmune (NEXI) +17%. Joby Aviation (JOBY) +17%. Losers: Icosavax (ICVX...
Enfusion, Inc. (ENFN) Q4 2021 Results Earnings Conference Call March 24, 2022, 05:00 PM ET Company Participants Ignatius Njoku - Head of Investor Relations, Thomas Kim - Chief Executive Officer Steve Dorton - Chief Financial Officer. Conference Call Participants Bhavan Suri - William Blair Pa...
Enfusion press release (NYSE:ENFN): Q4 GAAP EPS of -$2.26 misses by $0.02. Revenue of $31.85M (+40.6% Y/Y) beats by $1.44M. For further details see: Enfusion GAAP EPS of -$2.26 misses by $0.02, revenue of $31.85M beats by $1.44M
Strong Business Momentum Drove Fourth Quarter Revenue Growth of 41% Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-based investment management software and services, today announced financial results for the fourth quarter and year ended December 31, 2...
The Rule of 40 is a quantitative way to measure the potential of SaaS companies' growth to create value, even if they're not profitable yet. I created a portfolio of SaaS companies that pass the Rule of 40. This article series tracks the performance of the portfolio over time. ...
News, Short Squeeze, Breakout and More Instantly...
Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its second quarter 2024 financial results before the U.S. financial markets open on Tuesday, August 6, 2024. Management will host a confe...
2024-07-01 05:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-11 07:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...